![Du Qiang Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Du Qiang Wang
Directeur/Membre du Conseil chez NOVOPROTEIN SCIENTIFIC INC.
Postes actifs de Du Qiang Wang
Sociétés | Poste | Début | Fin |
---|---|---|---|
NOVOPROTEIN SCIENTIFIC INC. | Directeur/Membre du Conseil | 15/04/2021 | - |
Secrétaire Général | 15/04/2021 | - | |
Investor Relations Contact | - | - | |
Corporate Officer/Principal | 01/04/2010 | 15/04/2021 | |
Novoprotein Scientific (Shanghai), Inc.
![]() Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Directeur/Membre du Conseil | 12/08/2020 | - |
Historique de carrière de Du Qiang Wang
Formation de Du Qiang Wang
Fudan University | Graduate Degree |
Statistiques
Internationale
Chine | 4 |
Opérationnelle
Director/Board Member | 2 |
Graduate Degree | 1 |
Investor Relations Contact | 1 |
Sectorielle
Retail Trade | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVOPROTEIN SCIENTIFIC INC. | Commercial Services |
Entreprise privées | 1 |
---|---|
Novoprotein Scientific (Shanghai), Inc.
![]() Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Retail Trade |
- Bourse
- Insiders
- Du Qiang Wang
- Expérience